One recent BCG test found synthetic panels predicted real consumer choices with 92% accuracy after fine-tuning, yet the same research warns they shouldn't replace human studies for radically new products (BCG, 2026). That tension defines the 2026 synthetic-panel market. The technology is no longer a demo for innovation teams.
It is becoming a budget line for CPG, retail, media, financial services, and private equity firms that need faster readouts on concepts, claims, packaging, pricing, and creative before committing capital.
The point is not that artificial respondents are better than real consumers. It is that real consumer research has become too slow and expensive for the number of decisions enterprises now want to test.
A brand team that once tested three claims and two price points can now simulate 50 claim-price-package combinations overnight, then reserve human panels for choices that can change a launch forecast. Synthetic panels are less a replacement for research than a compression layer: they reduce the messy front end of product testing so real respondents are used where their signal matters most.
The winning product is not the fake consumer. It is the filter that decides when real consumers are worth the cost.
By August 2026, buyers are no longer asking only whether synthetic panels are credible. They are asking where synthetic output is allowed to influence decisions. The practical answer is tiered governance.
Synthetic panels can own low-risk ideation, screen early concepts, stress-test language, and flag weak hypotheses. They should support, not decide, medium-risk choices such as pack architecture, product attributes, and channel messaging. They should remain subordinate to human panels, behavioral tests, and sales pilots for pricing forecasts, regulated claims, clinical adjacency, financial-product messaging, and any category where minority consumer reactions can create brand or legal exposure. That boundary is where the market will be won.
The Faster Insight Budget Opens
The addressable pool starts at roughly $153 billion in global insights spending in 2024, but the serviceable market for synthetic panels is far narrower and more attractive (ESOMAR, 2024). ESOMAR's Global Market Research 2024 report put the broader insights industry at about $142 billion in 2023, up 8% from almost $130 billion.
Secondary summaries of ESOMAR's 2024 figures place the industry near $153 billion and the traditional market research sector near $56 billion (ESOMAR, 2024; Research World and ESOMAR, 2024). That $56 billion traditional research pool is the first hunting ground because it includes surveys, panels, concept tests, ad tests, and qualitative studies where artificial respondents can shorten cycle times.
The prize is not the whole research market. It is the repetitive, pre-decision work that buyers already dislike funding.
The second pool is customer experience and decision software. Gartner reported that worldwide customer experience and relationship management software reached $128 billion in 2024, up 13.4%, with cross-CRM segments growing 17.7% because richer customer profiles are becoming a base requirement for AI adoption (Gartner, 2025).
Synthetic panels sit between those two budgets. They do not only compete with research agencies; they also compete for dollars inside CRM, product analytics, and marketing operations platforms. The realistic 2026 serviceable available market is best framed as 3% to 6% of traditional market research plus a small share of CX analytics budgets, or roughly $2 billion to $5 billion, marked as an analyst estimate because vendors do not yet report synthetic-panel revenue as a clean category.
Growth pressure comes from AI budgets. IDC estimated global AI spending near $235 billion in 2024 and forecast more than $631 billion by 2028, implying an almost 30% compound annual growth rate. IDC also estimated GenAI at 17.2% of AI spending in 2024 and 32% by 2028, with a 60% five-year CAGR (IDC, 2024).
Bloomberg Intelligence sized GenAI revenue at $40 billion in 2022 and forecast $1.3 trillion by 2032, roughly 43% CAGR (Bloomberg Intelligence, 2024). Forrester forecast global tech spend at $4.7 trillion in 2024 and GenAI software reaching $227 billion by 2030 at 36% CAGR (Forrester, 2024). Synthetic panels will be pulled by those AI budgets when research heads can show lower sample spend, faster innovation cycles, and cleaner audit trails.
Regional adoption will split by data depth and legal tolerance. North America leads because Qualtrics, Suzy, PureSpectrum, NIQ, and many enterprise buyers sit close to large first-party datasets. Europe moves more slowly because EU AI Act transparency rules are now part of procurement, but the region's high research standards may favor data-grounded vendors over thin persona tools.
Asia-Pacific adoption is uneven: Japan, Australia, Singapore, and India are early enterprise markets, while cross-border consumer modeling remains harder where languages, retail channels, and social norms differ sharply. The inflection is historical as well as technical. From 2016 to 2023, market research digitized its collection layer. From 2024 to 2026, it began digitizing the respondent layer, which changes both speed and liability.
Incumbents Are Rebuilding Their Moats
The competitive field is splitting into data-rich incumbents, AI-native challengers, and workflow platforms that want synthetic panels to live inside daily decision tools. Qualtrics is the most visible enterprise platform in this shift.
In August 2025, Qualtrics announced a partnership with PureSpectrum under which PureSpectrum selected Qualtrics as its exclusive synthetic panel provider, while PureSpectrum became Qualtrics' exclusive quantitative panel provider inside the Qualtrics platform (Qualtrics, 2025). In March 2026, Qualtrics released prebuilt U.S. synthetic research panels powered by a custom model trained on its data stores, with U.K., Canada, and Australia panels planned later in the year, according to TechTarget.
Qualtrics' last public full-year revenue before its take-private transaction was $1.4586 billion in 2022, up 36%, giving it a large installed base for synthetic research cross-sell.
NIQ is the data-asset incumbent with the strongest claim in FMCG and retail measurement. Its 2025 revenue was $4.198 billion, up 5.7%, with Intelligence revenue of $3.394 billion and annualized Intelligence Subscription revenue of $2.877 billion (NIQ company filings, FY2025).
The company has embedded Ask Arthur, a GenAI feature, in its Discover platform and states that more than 74,000 active users generated more than 115 million reports in 2025 using its software applications (NIQ company filings, FY2025). NIQ's synthetic-panel angle is likely to be conservative: simulations grounded in retail, panel, ecommerce, and activation data, sold as decision support for assortments, pricing, product development, and promotion planning.
Ipsos remains a scale research agency with a human-panel credibility advantage. It reported 2025 revenue of EUR2.525 billion, up 3.4%, and operating margin of EUR309 million, or 12.3% (Ipsos, FY2025 results).
Ipsos' 2025 acquisition activity, including The BVA Family and infas, points to an appetite for deeper method coverage and public-sector data. Its position in synthetic panels is likely to emphasize validation discipline: paired human and artificial studies, category benchmarks, and defensible methodology for boards that will not accept black-box research outputs.
Kantar is using its AI Lab to protect premium brand and creative-testing franchises. Kantar says its AI Lab worked on more than 50 live R&D workstreams in 2025, including synthetic data, AI personas, agentic AI pipelines for creative and innovation, and chat-based AI assistants (Kantar AI Lab, 2026).
Kantar's published view is cautious: synthetic data can increase sample size and speed, but off-the-shelf large language models are a poor strategy without high-quality, problem-specific data (Kantar, 2025). Kantar is privately held, so revenue is not as transparent as Ipsos or NIQ, but its competitive asset is decades of ad, brand, panel, and creative effectiveness datasets that can make artificial respondents less generic.
GWI is a specialist with a clear synthetic-audience product story. It says GWI Synthetic Audiences are grounded in more than 2 million annual interviews across 53 markets and 40 billion unique data points, with weekly data refreshes (GWI, 2026).
In September 2025, GWI launched the Spark API, and in January 2026 it launched Agent Spark for use in LLM environments including ChatGPT and Claude, saying users can analyze more than 35 billion data points in seconds (GWI, 2026). GWI does not disclose revenue, but its strategic position is clear: it wants to be the human-data layer inside AI agents, agency workflows, and strategy dashboards.
Suzy is the venture-backed challenger built around real-time consumer access rather than legacy agency service. Public company pages and founder materials cite more than $130 million in venture funding, a $50 million Series D, and more than $25 million ARR in 2021.
Other public portfolio materials cite $68.7 million in annual revenue by 2025, which should be treated as an external estimate rather than audited company filing. In 2025, Suzy launched Suzy Speaks for AI qualitative work and Suzy Signals for trend intelligence, putting it closer to continuous research and early product testing. Its advantage is speed and workflow design for enterprise teams that do not want every concept routed through a traditional research department.
The share gainer is not automatically the vendor with the flashiest artificial persona. Share is moving toward firms that combine three things: consented or directly collected data, model refresh discipline, and procurement-grade proof that synthetic output predicts real behavior.
That favors Qualtrics, GWI, NIQ, Kantar, and Ipsos in enterprise accounts, while Suzy and other challengers can win where speed and ease matter more than global methodology sign-off. The mechanism is simple: synthetic panels are bought on trust, not novelty.
Regulation Makes Buyers Pick Sides
The concrete trigger in 2026 is the EU AI Act's 2 August 2026 enforcement start for applicable transparency rules, GPAI enforcement powers, prohibitions, and AI literacy obligations (European Commission AI Act Service Desk, 2026).
Synthetic panels may not always be high-risk AI systems, but they are AI systems producing content and decision inputs that can affect consumer targeting, claims testing, pricing, and product-market fit decisions. That brings them into procurement reviews, data protection reviews, and marketing compliance reviews even when the final business decision remains human-led.
The regulatory effect is larger than Europe. Multinational buyers tend to standardize vendor requirements around the strictest region because separate research governance rules by geography are operationally expensive.
A U.S. CPG company testing a snack claim in Germany, France, and the U.K. will not want one synthetic-panel policy for Europe and another for the U.S. It will ask vendors to disclose training-data provenance, explain how artificial respondents are generated, show bias testing, and provide audit trails for which outputs influenced which launch decisions. That raises barriers for generic persona tools trained on internet-scale data with weak respondent lineage.
The second trigger is the FTC's Consumer Reviews and Testimonials Rule, effective 21 October 2024, which targets fake or deceptive consumer reviews and testimonials (FTC, 2024). Synthetic panels are not consumer reviews, but the rule sharpens the boundary between internal research simulation and external consumer representation.
A synthetic quote cannot be repackaged as a real consumer quote. A simulated preference cannot be cited in advertising as market proof without clear basis. Vendors that treat artificial respondents as internal decision aids will handle this better than vendors that encourage clients to blur simulation, testimonial, and evidence.
The result is a governance market. Buyers now need policy tiers, source documentation, confidence scoring, and rules for when real people must be brought back in. That does not slow adoption; it channels adoption toward paid enterprise platforms. The irony is that regulation may help synthetic panels commercialize faster because it gives CFOs and legal teams a language for acceptable use.
Three Ways This Can Break
The first risk is false precision, with a 55% probability that at least one major enterprise buyer publicly reins in synthetic-panel use by mid-2027 after an avoidable product or messaging miss.
The mechanism is familiar: a model trained on historical category data performs well for incremental changes, then overstates confidence on a new format, emerging subculture, or crisis-sensitive claim. CPG, beauty, health-adjacent wellness, and financial services are most exposed because small wording differences can shift trust. The timeline is short because 2026 pilots are moving from insight teams into marketing and product squads that may not understand sample quality.
The danger is not that synthetic panels are wrong. It is that their wrong answers can arrive with managerial confidence.
The second risk is demographic flattening, with a 40% probability of becoming a board-level issue in regulated or reputation-sensitive categories within 18 months. Synthetic respondents often produce coherent majority answers while muting minority views, edge cases, and cultural contradictions.
BCG explicitly warns that such models can overlook minority views and are less effective for radically new products (BCG, 2026). This affects vendors that cannot prove segment-level fidelity, especially in multicultural markets, youth categories, low-incidence health segments, and political or social-issue research. The practical damage is not only wrong averages; it is the missed veto group that turns a launch into a backlash.
The third risk is data-rights contamination, with a 30% probability of procurement delays for vendors using poorly documented training data by late 2026. EU AI Act GPAI obligations require technical documentation, copyright policies, and summaries of training content for certain model providers.
Downstream buyers are asking parallel questions even when the synthetic-panel vendor is not the foundation-model provider (European Commission, 2025 and 2026). If a vendor cannot explain whether responses are grounded in consented panel data, licensed survey assets, CRM data, or scraped public text, legal teams will treat the output as difficult to defend. That matters most to platform vendors trying to sell into pharmaceuticals, financial services, alcohol, children's products, and public-sector research.
The tail risk most analysts underweight is research budget cannibalization before validation maturity. CFOs may see synthetic panels as a way to cut human panel spend by 30% to 50%, an analyst estimate based on common substitution targets in enterprise cost programs, before the organization has run enough paired studies.
If procurement forces substitution too early, insight quality drops while the vendor market still books growth. That creates a delayed correction: brands first celebrate speed, then discover that weak synthetic governance has moved error from the research budget into inventory, media, and brand equity.
Buyers Need Consequence Tiers
Enterprise buyers should separate decisions by consequence, not by department. A naming screen, package color test, or early concept ranking can rely heavily on synthetic panels if the vendor shows source grounding and confidence intervals.
A price elasticity estimate, health claim, financial-product message, or major launch forecast should require a human panel, behavioral test, or in-market pilot before capital is committed. This tiering should be written into procurement, not left to individual brand managers.
Buyers should run calibration studies before scaling. Two or three categories are enough to start: one mature category, one high-growth category, and one culturally sensitive or low-incidence segment. Run a synthetic study beside a human panel and compare direction, magnitude, and subgroup errors.
BCG's 92% result is encouraging, but it came with fine-tuning and defined use cases (BCG, 2026). The right internal benchmark is not vendor demo accuracy; it is repeatable prediction against that company's own category, brand, and channel data.
Contracts should require data lineage, refresh cadence, model-change notification, and a ban on using client confidential results to train shared models without explicit consent. That clause matters because synthetic panels improve when real client outcomes feed back into them. The buyer wants learning, but not a pooled dataset that lets competitors benefit from its launch failures.
Investors Should Follow The Data
Investors should value proprietary respondent data more highly than conversational interface design. The interface will commoditize as LLM agents improve. The durable asset is permissioned, frequently refreshed human data with enough depth to support segment-specific simulation.
GWI's claim of more than 2 million annual interviews across 53 markets and NIQ's 115 million software reports generated in 2025 are the kinds of usage and data-scale indicators that matter (GWI, 2026; NIQ filings, FY2025).
Due diligence should test whether reported growth is substitution, expansion, or workflow capture. Substitution replaces human panels with cheaper synthetic tests, which can lift margins but may cap revenue.
Expansion creates new test volume that never existed before, which is the better case. Workflow capture embeds synthetic insight into product, marketing, and strategy systems, which can create stickier software revenue. The highest-quality assets will show all three, with expansion leading.
Private equity investors should be careful with agency roll-ups. A traditional agency that bolts on a generic AI tool may show near-term margin improvement but lose trust if outputs are not validated.
The more attractive acquisition target owns panel data, category benchmarks, workflow software, and recurring enterprise contracts. That profile looks more like NIQ, GWI, Qualtrics, or Suzy than a pure services shop with AI branding.
Vendors Must Sell Proof
Vendors should stop selling synthetic panels as faster focus groups and start selling governed decision systems. Enterprise buyers need to know when the tool is right, when it is not, and what proof exists.
Product pages should show validation ranges by category and use case, not only claims about seconds to insight. Kantar's public caution that off-the-shelf LLMs are often a poor strategy is directionally right because buyers are becoming more method-literate (Kantar, 2025).
The stronger sales pitch is restraint. A vendor that admits weak spots will be trusted with stronger decisions.
Vendors should publish model cards for synthetic respondents in plain commercial language: source data, refresh timing, geography, respondent consistency, segment coverage, known weak spots, and human validation results.
They should also integrate with tools where decisions happen, such as Qualtrics research workflows, GWI Spark API partners, CRM systems, product management systems, and board reporting packs. The vendor that becomes the audit trail for insight decisions will defend price better than the vendor that only answers prompts.
Vendors also need clear pricing architecture. Per-seat pricing works for broad access, but product-testing teams need study-level controls, usage ceilings, and premium pricing for validated decision tiers. The best model is hybrid: subscription access for low-risk exploration, higher-priced validated modules for conjoint, concept screening, creative testing, and claims support.
The Next Two Years Split Winners
The base case, assigned a 60% probability, is that synthetic panels become a standard pre-test layer by 2028 while human research retains authority for final validation.
Under this path, large CPG, retail, media, and financial-services companies add synthetic testing to insight platforms, but procurement requires paired validation for high-stakes decisions. Revenue grows faster than the traditional research sector because synthetic panels expand the number of tested decisions. The serviceable market reaches roughly $4 billion to $7 billion by 2028, an analyst estimate anchored to ESOMAR's traditional research pool and IDC's AI spending growth.
The contrarian view, assigned a 25% probability, is that synthetic panels become more important than many research leaders expect because they change who can do research.
If sales, product, category management, and finance teams can ask grounded audience questions directly inside AI agents, the bottleneck moves from survey fielding to governance. GWI's Agent Spark and Spark API partnerships point to this path. In that scenario, synthetic panels do not take share only from panel spend; they take share from ad-hoc consulting, desk research, and slow internal analytics queues.
The downside scenario, assigned a 15% probability, is a trust shock. A high-profile brand could launch a claim, price move, or product variant heavily informed by synthetic respondents, then miss badly in-market.
If litigation, regulator attention, or public criticism follows, enterprise buyers will freeze unsupervised use and require human validation for most decisions. The category would still survive, but growth would shift back toward incumbents with audit trails and away from AI-native tools that cannot prove source quality.
Three leading indicators deserve close tracking. First, watch the share of synthetic-panel studies that are paired with human validation in vendor case studies; a rising share means the market is professionalizing.
Second, watch renewal rates and expansion revenue from enterprises, especially at Qualtrics, NIQ, and GWI, because expansion shows synthetic panels are creating new workflows rather than one-time pilots. Third, watch EU AI Act procurement language in RFPs after 2 August 2026; the inclusion of training-data summaries, transparency controls, and model-change notices will signal that synthetic panels have moved from innovation pilots into governed operating systems. Related MarketIntel coverage of enterprise AI adoption can be tracked at MarketIntel.
Seven Takeaways For Decision Makers
- Synthetic panels are most useful for early screening, claim language, concept iteration, and packaging choices, not final demand forecasting for major launches.
- The credible 2026 serviceable market is roughly $2 billion to $5 billion, an analyst estimate tied to ESOMAR's $56 billion traditional research sector and Gartner's $128 billion CX and CRM software market.
- BCG's reported 92% predictive accuracy shows the upside, but its own caution on radical innovation and minority views defines the governance boundary.
- Data-rich vendors such as Qualtrics, NIQ, Kantar, Ipsos, and GWI have a structural advantage over thin persona tools because buyers now ask for source lineage.
- The EU AI Act's 2 August 2026 enforcement milestone turns synthetic-panel procurement into a documentation and transparency exercise, not only a software evaluation.
- CFO-driven cost cutting is the category's hidden risk because premature replacement of human panels can move research error into inventory, media, and brand damage.
- The next durable product category is the audited synthetic insight layer inside AI agents, CRM systems, and product workflows, not standalone chat with artificial consumers.
What Executives Are Really Asking
CFO question: Can synthetic panels actually reduce research spend without raising launch risk? Synthetic panels can reduce spend in the early stages of product testing, but the saving should be measured as fewer low-quality human studies and faster narrowing of options, not full replacement.
A practical 2026 model is to let synthetic panels screen 30 to 70 early variants, then pay for human research on the final five to ten. BCG's 92% accuracy test supports this direction for specific use cases, but BCG also says synthetic panels cannot replace traditional research for radically new product ideas (BCG, 2026). CFOs should demand a calibration dashboard showing how synthetic results matched past human studies, sales pilots, or A/B tests. Without that, a budget cut may only push cost into failed launches.
CTO question: Should this capability be built internally or bought from a vendor? Most enterprises should buy the first system and build governance around it. Internal teams can connect CRM, product, and sales data, but few companies own high-quality, consented consumer panels at the scale of NIQ, GWI, Ipsos, Kantar, Qualtrics, or PureSpectrum.
GWI cites more than 2 million annual interviews across 53 markets, while NIQ reported 74,000 active software users and 115 million reports generated in 2025 (GWI, 2026; NIQ filings, FY2025). Those data assets are hard to replicate. Internal build makes sense only when a company has large first-party datasets, frequent research needs, strict confidentiality, and enough methodology talent to validate synthetic outputs against real behavior.
PE investor question: Where is the acquisition angle in synthetic consumer insights? The best acquisition targets own proprietary data, workflow software, and validation proof. Agencies with weak technology may become margin-improvement plays, but they will not command premium multiples if their synthetic capability is only a wrapper around a general model.
Software-led vendors with recurring contracts, panel access, and evidence of expansion revenue are better positioned. Qualtrics' last public revenue was $1.4586 billion in 2022, NIQ reported $4.198 billion in 2025 revenue, and Ipsos reported EUR2.525 billion in 2025 revenue, which shows that scale players already have budgets and relationships to absorb this category. PE buyers should test whether synthetic panels increase study volume, shorten sales cycles, or only discount existing research.
CFO question: What controls belong in vendor contracts before synthetic panels touch product decisions? Contracts should require training-data provenance, refresh frequency, geographic coverage, model-change notices, confidentiality terms, and rights over client feedback loops.
The vendor should disclose whether artificial responses are grounded in real panel data, behavioral data, client-owned data, or general model inference. The EU AI Act makes these questions more pressing because transparency rules and enforcement powers apply from 2 August 2026 for several AI obligations (European Commission AI Act Service Desk, 2026). A CFO should also require decision-tier language: which outputs can guide ideation, which require human confirmation, and which cannot be used for claims, pricing, or forecasts without a real-world check. This turns synthetic research from an experiment into a controlled operating process.
CTO question: How should accuracy be tested when vendors make different claims? Accuracy should be tested against decisions, not vibes. A buyer should select completed historical studies where the company has human panel data and later market outcomes, then ask vendors to recreate predictions using only data that would have been available before the decision date.
That avoids future-data leakage, which can make any model look smarter than it was. BCG's 92% result is a useful reference point, but every enterprise needs its own category-level benchmark because beverage, banking, apparel, and healthcare-adjacent products do not behave the same. The best test compares direction, rank order, magnitude, subgroup error, and consistency across repeated runs. Vendors that resist this process should be treated as higher risk regardless of demo quality.
Faster Research Needs Real Anchors
Synthetic panels will matter because they answer a real executive problem: the number of testable decisions has grown faster than research budgets and human respondent capacity. The market should not be judged by whether artificial respondents can replace people.
That framing misses the economic point. The winning use case is triage: test more ideas, kill weak options earlier, and spend real respondent dollars where the decision has financial or reputational consequence.
The companies best placed for 2026 and 2027 are those with permissioned data, category benchmarks, clear validation evidence, and procurement-ready governance.
Qualtrics brings platform reach, PureSpectrum brings panel supply, NIQ brings FMCG and retail data, Ipsos and Kantar bring methodology trust, GWI brings a focused human-data API strategy, and Suzy brings enterprise speed. AI-native challengers can still win, but only if they prove they are more than persona generators.
Executives should watch three things: whether synthetic-panel vendors publish validation by use case, whether EU AI Act procurement clauses become standard in RFPs, and whether CFOs treat the tool as research expansion rather than blunt cost removal.
By 31 December 2027, at least three of the ten largest global CPG companies will require every major concept-screening workflow to include a synthetic pre-test and a documented human validation gate before launch approval.
--- [✉️ Talk to us](https://marketintel.co.in/contact) · [Subscribe to our Newsletter](https://marketintel.co.in/newsletter) --- ### Related Articles - [Why Corporate Boards Are Wrong About Supply Chain Resilience](why-corporate-boards-are-wrong-about-supply-chain-resilience-baea20a2) - [AlphaSense Hitting $400 Million ARR Will Kill Dashboard Theater](why-market-intelligence-agents-will-kill-dashboard-theater-829f0a82) - [Answer Engines Capture The First B2B AI Search Shortlist](stop-treating-your-website-as-b2b-discoverys-front-door-b6b46820)See our Gartner research for deeper analysis.